Scientists successfully sequence the RNA from woolly mammoths found in Siberia that lived up between 10,000 thousand and ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability ...

Study finds protein traits and CHO-cell gene programs drive therapeutic protein yields, guiding biomanufacturing.

In the study, published in Science Translational Medicine on Nov. 5, researchers identified proteins expressed on the surface ...

BioGeneric Pharma was chosen by the World Health Organisation (WHO) in February last year to receive the technology to produce mRNA vaccines, therapeutic proteins, and immunoglobulins for treating ...

Many climate scientists call our current epoch the “Anthropocene” — the first human-driven climate era. Many technologists ...

RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has ...

At a margin of 40%, Palantir delivered $476 million net income (GAAP). Overall, the company now has $6.4 billion in cash and cash equivalents. More importantly for investors, Palantir raised its FY ...

It will be the first era in which humanity must govern, innovate, collaborate and coexist at a planetary scale in order to ...

Research reveals mRNA COVID-19 vaccines may enhance cancer immunotherapy effectiveness, extending survival for lung and skin ...

Transplant Québec is proud to announce its participation in the 17th biennial conference held by the International Society for Organ Donation Professionals (ISODP). This event will take place in Kyoto ...